Skip to main content

Table 1 Comparison of characteristics in outcome-stratified patients without previous antiplatelet therapy

From: High-sensitivity C-reactive protein as a better predictor of post-thrombolytic functional outcome in patients with previous antiplatelet therapy

Characteristic

Mean (SD) or median (Q1–Q3)/N (%)

P-value

Non-antiplatelet history

mRS ≤ 2 (n = 93)

mRS > 2 (n = 70)

Age

63.82 ± 12.11

68.71 ± 10.18

0.007

HS.CRP

3.40 (1.27–9.36)

4.29 (1.75–13.30)

0.063

Creatinine

71.83 ± 15.45

68.86 ± 19.45

0.279

Uric acid

306.28 ± 98.39

310.28 ± 91.72

0.792

Platelet count

199.08 ± 52.99

185.09 ± 50.81

0.091

NIHSS

4.00 (2.00–8.00)

10.00 (6.00–15.00)

< 0.001

TC

4.31 ± 0.91

4.65 ± 1.69

0.101

TG

1.22 (0.84–1.61)

1.30 (0.96–1.56)

0.213

HDLC

1.14 (1.01–1.26)

1.19 (1.07–1.41)

0.124

LDLC

2.53 ± 0.71

2.66 ± 0.70

0.236

VOLUME

1.98 (0.39–11.23)

6.17 (1.22–56.35)

< 0.001

GRASPS

70.84 ± 6.64

76.07 ± 8.18

< 0.001

SBP

150.46 ± 19.72

150.76 ± 23.74

0.931

DBP

85.39 ± 11.24

90.34 ± 20.15

0.048

FBG

5.61 (4.76–6.75)

6.01 (5.31–6.93)

0.054

Hypertension

0.006

 No

42 (45.16)

17 (24.29)

 

 Yes

51 (54.84)

53 (75.71)

 

Diabetes

0.488

 No

73 (78.49)

58 (82.86)

 

 Yes

20 (21.51)

12 (17.14)

 

Coronary heart disease

0.773

 No

91 (97.85)

68 (97.14)

 

 Yes

2 (2.15)

2 (2.86)

 

Stroke

0.161

 No

87 (93.55)

61 (87.14)

 

 Yes

6 (6.45)

9 (12.86)

 

Gender

0.183

 No

23 (24.73)

24 (34.29)

 

 Yes

70 (75.27)

46 (65.71)

 

Self-transferring

0.083

 No

77 (82.80)

50 (71.43)

 

 Yes

16 (17.20)

20 (28.57)

 

ASPECTS

< 0.001

 7

0 (0.00)

5 (7.14)

 

 8

3 (3.23)

3 (4.29)

 

 9

14 (15.05)

26 (37.14)

 

 10

76 (81.72)

36 (51.43)

 

HF

0.628

 No

89 (95.70)

68 (97.14)

 

 Yes

4 (4.30)

2 (2.86)

 

Smoking

 No

68 (73.12)

46 (65.71)

0.308

 Yes

25 (26.88)

24 (34.29)

 
  1. Data are presented as mean ± standard deviation values or n (%)
  2. CRP C-reactive protein, NIHSS National Institutes of Health Stroke Scale, TC total cholesterol, TG total glyceride, HDLC high-density lipoprotein cholesterol, LDLC low-density lipoprotein cholesterol, GRASPS, SBP systolic blood pressure, DBP diastolic blood pressure, ASPECTS Alberta Stroke Program Early CT Score, HF heart failure